Genetic Metabolic Dietitians International (GMDI) brought together leading practitioners in nutrition therapy for education, training, advocacy, and research.
Travere at GMDI 2024
Travere Therapeutics was excited to participate in this year’s event and engage with metabolic dietitians. We look forward to seeing you next year.
Program
Latest Results From the COMPOSE® Phase 1/2 Trial for the Treatment of Classical Homocystinuria (HCU) Using Pegtibatinase, a Novel Investigational Enzyme Replacement Therapy
Speakers: Jaya Ganesh, Janet Thomas, Wendy E. Smith, Melissa Lah, David Kudrow, Jalé Güger, Sharon McDermott, Sagar A. Vaidya, Liz Wilkening, Harvey Levy, Can Ficicioglu
Type: Poster
Contact Your Travere MSL
Our Medical Science Liaisons (MSLs) are available to answer questions and provide support on Travere products.
Contact an MSLNovel Dietary Management Strategies for Classical Homocystinuria (HCU) in HARMONY/ENSEMBLE Phase 3 Studies of Pegtibatinase, an Investigational Enzyme Replacement Therapy
Speakers: Janet Thomas, Tawfeg Ben-Omran, Harvey Levy, François Maillot, Stephan vom Dahl, Sharon McDermott, Sergio Slawka, Can Ficicioglu
Type: Poster
SING: A Novel Tool for Dietary Management and Monitoring in Clinical Trials of Pegtibatinase, an Investigational Enzyme Replacement Therapy for Classical Homocystinuria
Speakers: Elaina Jurecki, Sommer Gaughan, Sandra Van Calcar, Lauren Dwyer, John Shea, Kassi Swallow
Type: Poster
MA-DS-24-0022 | August 2024